UPDATE 1-FDA approves Boehringer-Lilly drug for type-2 diabetes patients
February 02, 2015 at 09:33 AM EST
Feb 2 (Reuters) - The U.S. Food and Drug Administration approved a drug developed by Eli Lilly and Co and Boehringer Ingelheim Pharmaceuticals Inc to improve blood sugar control in type-2 diabetes patients, the companies said.
